CSET's Dewey Murdick and Owen Daniels shared their insights in a TIME op-ed. They discuss the issue of the Chinese government's recent move to restrict global access to a substantial amount of public data. Read More
In an article published by The New York Times that discusses the increasing use of artificial intelligence in political campaigns and the concerns it raises regarding disinformation and manipulation, CSET's Josh A. Goldstein provides his expert insight. Read More
CSET's AI Assessment team provides a template that helps organizations create profiles to guide the management and deployment of AI systems in line with NIST's AI Risk Management Framework. Read More
CSET's Andrew Lohn and Joshua A. Goldstein share their insights on the difficulties of identifying AI-generated text in disinformation campaigns in their op-ed in Lawfare. Read More
CSET's Jenny Jun was featured in the Atlantic Council's The 5x5, a series that showcases five experts answering five questions on a common theme, trend, or current event in the world of cyber. Read More
In a Washington Post article, it was mentioned that Dewey Murdick, Executive Director of CSET, was among the industry leaders invited to speak during the briefing with senators. Read More
The Washington Post cited a CSET report that delves into the issue of talent retention in artificial intelligence and its effects on the United States' competitiveness. The report was referenced in an article discussing how countries such as the United Kingdom, Australia, and Canada are successfully attracting highly skilled immigrants, including international students educated in the United States. Read More
In an article by The Wall Street Journal, CSET's Emily S. Weinstein contributed her expertise to the discussion surrounding the challenge faced by the Biden administration in identifying artificial intelligence that poses a threat to national security. Read More
Steph Batalis, Caroline Schuerger and Vikram Venkatram explore three notable areas in the life sciences where LLMs are catalyzing meaningful advances: drug discovery, genetics, and precision medicine. Read More
This website uses cookies.
To learn more, please review this policy. By continuing to browse the site, you agree to these terms.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.